RU2014140795A - Активированная иммуностимулирующая клеточная композиция, используемая для лечения инфекционных заболеваний - Google Patents

Активированная иммуностимулирующая клеточная композиция, используемая для лечения инфекционных заболеваний Download PDF

Info

Publication number
RU2014140795A
RU2014140795A RU2014140795A RU2014140795A RU2014140795A RU 2014140795 A RU2014140795 A RU 2014140795A RU 2014140795 A RU2014140795 A RU 2014140795A RU 2014140795 A RU2014140795 A RU 2014140795A RU 2014140795 A RU2014140795 A RU 2014140795A
Authority
RU
Russia
Prior art keywords
composition
treating
dendritic cells
infection
viral infection
Prior art date
Application number
RU2014140795A
Other languages
English (en)
Russian (ru)
Inventor
Ирен Гинис
Алан Смит
Марина БУБИС
Митчелл Ширван
Original Assignee
Макрокьюэ, Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Макрокьюэ, Лтд. filed Critical Макрокьюэ, Лтд.
Publication of RU2014140795A publication Critical patent/RU2014140795A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/46—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Hematology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2014140795A 2012-03-15 2013-03-13 Активированная иммуностимулирующая клеточная композиция, используемая для лечения инфекционных заболеваний RU2014140795A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261611180P 2012-03-15 2012-03-15
US61/611,180 2012-03-15
PCT/IB2013/000935 WO2013136191A1 (en) 2012-03-15 2013-03-13 Activated immunostimulatory cell composition for therapy of infection

Publications (1)

Publication Number Publication Date
RU2014140795A true RU2014140795A (ru) 2016-05-10

Family

ID=48483110

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014140795A RU2014140795A (ru) 2012-03-15 2013-03-13 Активированная иммуностимулирующая клеточная композиция, используемая для лечения инфекционных заболеваний

Country Status (8)

Country Link
US (1) US20150071892A1 (2)
EP (1) EP2825182A1 (2)
JP (1) JP2015509974A (2)
CA (1) CA2864838A1 (2)
IN (1) IN2014DN08407A (2)
MX (1) MX2014010893A (2)
RU (1) RU2014140795A (2)
WO (1) WO2013136191A1 (2)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103209682A (zh) 2010-09-09 2013-07-17 马克罗柯尔有限公司 活化白血球调节上清液以及用于伤口愈合的用途
WO2018057447A1 (en) * 2016-09-23 2018-03-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of preparing an isolated population of dendritic cells and methods of treating cancer using same
JPWO2019069561A1 (ja) * 2017-10-03 2020-10-22 公益財団法人東京都医学総合研究所 インフルエンザに対する医薬

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713739B1 (en) 2000-11-17 2010-05-11 Novartis Vaccines And Diagnostics, Inc. Microparticle-based transfection and activation of dendritic cells
KR101131727B1 (ko) 2004-06-11 2012-03-28 가톨릭대학교 산학협력단 ＣＥＡ-특이적인 세포독성 Ｔ세포를 생성하는 재조합 아데노바이러스 ＡｄＶＣＥＡ로 트랜스덕션된 수지상세포, 이를 포함하는 백신 및 약제학적 조성물
EP1748067A1 (en) 2005-07-29 2007-01-31 Institut Pasteur Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes
CA2867976A1 (en) 2009-03-05 2010-09-10 Macrocure, Ltd. Activated leukocyte composition

Also Published As

Publication number Publication date
WO2013136191A1 (en) 2013-09-19
EP2825182A1 (en) 2015-01-21
IN2014DN08407A (2) 2015-05-08
US20150071892A1 (en) 2015-03-12
MX2014010893A (es) 2015-06-23
JP2015509974A (ja) 2015-04-02
CA2864838A1 (en) 2013-09-19

Similar Documents

Publication Publication Date Title
RU2010111747A (ru) Способ получения противовирусных вакцин
RU2015109132A (ru) Пролекарственная форма тенофовира и ее фармацевтические применения
EA201591027A1 (ru) Полициклические карбамоилпиридоновые соединения и их фармацевтическое применение
JP2019520061A5 (2)
NZ628515A (en) Antiviral compounds with a dibenzooxaheterocycle moiety
RU2012146775A (ru) Вирусная частица, высвобождающаяся после инфицирования клеток млекопитающих цитомегаловирусом человека (hcmv), содержащая слитый белок, и ее применение
MX2022001967A (es) Composiciones de células t específicas para virus de terceros y métodos para prepararlas y usarlas en profilaxis antiviral.
WO2011146612A3 (en) Latent human immunodeficiency virus reactivation
Andrieu et al. A dendritic cell‐based vaccine for treating HIV infection: background and preliminary results
PT1002055E (pt) Recuperacao de virus a partir de culturas celulares utilizando uma solucao salina hipertonica
CN115040517A (zh) 石蒜碱在防治svcv感染中的应用
ATE401392T1 (de) Subtypabgestimmte inaktivierte vollvirusvakzine zur behandlung von patienten mit hiv-infektion
RU2522868C1 (ru) Способ изготовления вакцины против ящура
CN102397538A (zh) 亚甲蓝光化学病毒灭活方法制备的病毒疫苗的应用
CN114869883B (zh) Esi-09在防治svcv感染中的应用
RU2015140469A (ru) Соединения для улучшенной дифференцировки стволовых клеток в гепатоциты
RU2522780C2 (ru) Способ получения вакцины против инфекционного ринотрахеита крупного рогатого скота
Sneller et al. HIV/IL-2 and EBV-associated lymphoproliferative diseases: cause and effect or coincidence?
CN103585155B (zh) Trigolutesins A在治疗肾综合征出血热药物中的应用
CN108220250A (zh) 一种扩繁家蚕核型多角体病毒的方法
CN103463002B (zh) Racemosins A在制备治疗肾综合征出血热药物中的应用
Dunnick et al. The future of interferon as an antiviral drug
RU2012134084A (ru) Вакцина против ящура типа а инактивированная сорбированная
RU2011125957A (ru) Способ иммунокоррекции клеточного и гуморального звена иммунитета у детей при папилломавирусной инфекции кожи
CN104056268A (zh) 一种具有抗人乳头瘤病毒及子宫内膜炎症的新型制剂

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20160314